The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Erectile Dysfunction Drugs Market Research Report 2025

Global Erectile Dysfunction Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1431392

No of Pages : 92

Ask Your Query

Report Description
Table of Content

Synopsis
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

The global Erectile Dysfunction Drugs market was valued at US$ 4855 million in 2023 and is anticipated to reach US$ 7335.2 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.

North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.

The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.

This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Drugs.

Report Scope

The Erectile Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Pill) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Erectile Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.

Segment by Type

Sildenafil
Tadalafil
Others

Segment by Application

Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina, Colombia)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Erectile Dysfunction Drugs Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction Drugs
1.2 Erectile Dysfunction Drugs Segment by Type
1.2.1 Global Erectile Dysfunction Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Drugs Segment by Application
1.3.1 Global Erectile Dysfunction Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Erectile Dysfunction Drugs Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Drugs Revenue 2019-2030
1.4.2 Global Erectile Dysfunction Drugs Sales 2019-2030
1.4.3 Global Erectile Dysfunction Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Drugs Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Erectile Dysfunction Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Erectile Dysfunction Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction Drugs, Product Type & Application
2.7 Erectile Dysfunction Drugs Market Competitive Situation and Trends
2.7.1 Erectile Dysfunction Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Erectile Dysfunction Drugs Players Market Share by Revenue
2.7.3 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Erectile Dysfunction Drugs Retrospective Market Scenario by Region
3.1 Global Erectile Dysfunction Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Erectile Dysfunction Drugs Global Erectile Dysfunction Drugs Sales by Region: 2019-2030
3.2.1 Global Erectile Dysfunction Drugs Sales by Region: 2019-2024
3.2.2 Global Erectile Dysfunction Drugs Sales by Region: 2025-2030
3.3 Global Erectile Dysfunction Drugs Global Erectile Dysfunction Drugs Revenue by Region: 2019-2030
3.3.1 Global Erectile Dysfunction Drugs Revenue by Region: 2019-2024
3.3.2 Global Erectile Dysfunction Drugs Revenue by Region: 2025-2030
3.4 North America Erectile Dysfunction Drugs Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Erectile Dysfunction Drugs Sales by Country (2019-2030)
3.4.3 North America Erectile Dysfunction Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Erectile Dysfunction Drugs Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Erectile Dysfunction Drugs Sales by Country (2019-2030)
3.5.3 Europe Erectile Dysfunction Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Erectile Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Erectile Dysfunction Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Erectile Dysfunction Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erectile Dysfunction Drugs Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Erectile Dysfunction Drugs Sales by Country (2019-2030)
3.7.3 Latin America Erectile Dysfunction Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Drugs Sales by Type (2019-2030)
4.1.1 Global Erectile Dysfunction Drugs Sales by Type (2019-2024)
4.1.2 Global Erectile Dysfunction Drugs Sales by Type (2025-2030)
4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2019-2030)
4.2 Global Erectile Dysfunction Drugs Revenue by Type (2019-2030)
4.2.1 Global Erectile Dysfunction Drugs Revenue by Type (2019-2024)
4.2.2 Global Erectile Dysfunction Drugs Revenue by Type (2025-2030)
4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Erectile Dysfunction Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Erectile Dysfunction Drugs Sales by Application (2019-2030)
5.1.1 Global Erectile Dysfunction Drugs Sales by Application (2019-2024)
5.1.2 Global Erectile Dysfunction Drugs Sales by Application (2025-2030)
5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2019-2030)
5.2 Global Erectile Dysfunction Drugs Revenue by Application (2019-2030)
5.2.1 Global Erectile Dysfunction Drugs Revenue by Application (2019-2024)
5.2.2 Global Erectile Dysfunction Drugs Revenue by Application (2025-2030)
5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Erectile Dysfunction Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly Erectile Dysfunction Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Erectile Dysfunction Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Erectile Dysfunction Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Corporation Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Corporation Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Corporation Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharma Erectile Dysfunction Drugs Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.6.1 Dong-A ST Corporation Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dong-A ST Erectile Dysfunction Drugs Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Metuchen Pharma
6.8.1 Metuchen Pharma Corporation Information
6.8.2 Metuchen Pharma Description and Business Overview
6.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Portfolio
6.8.5 Metuchen Pharma Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Corporation Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 CSBIO.
6.10.1 CSBIO. Corporation Information
6.10.2 CSBIO. Description and Business Overview
6.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CSBIO. Erectile Dysfunction Drugs Product Portfolio
6.10.5 CSBIO. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Drugs Industry Chain Analysis
7.2 Erectile Dysfunction Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Drugs Production Mode & Process
7.4 Erectile Dysfunction Drugs Sales and Marketing
7.4.1 Erectile Dysfunction Drugs Sales Channels
7.4.2 Erectile Dysfunction Drugs Distributors
7.5 Erectile Dysfunction Drugs Customers
8 Erectile Dysfunction Drugs Market Dynamics
8.1 Erectile Dysfunction Drugs Industry Trends
8.2 Erectile Dysfunction Drugs Market Drivers
8.3 Erectile Dysfunction Drugs Market Challenges
8.4 Erectile Dysfunction Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Netilmicin Market Research Report 2025

Global CD25 (IL2R alpha) ELISA Kit Market Research Report 2025

Global Algae Oil DHA Gummies Market Research Report 2025

Global Life Sciences Microscopy Devices Market Research Report 2025

Global Liposomes Drug Delivery Market Research Report 2025

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}